Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

65.59 

-1.07 -1.6%

as of Jun 24 '19

52 Week Range:

56.69 83.88


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Water Purification and Filtration segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratory and pharmaceutical, food and beverage, and commercial industrial customers. The company's Healthcare Disposables segment offers biological indicators, chemical integrators, sterilization pouches, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, amalgam separators, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jul '08 Jul '09 Jul '10 Jul '11 Jul '12 Jul '13 Jul '14 Jul '15 Jul '16 Jul '17 Jul '18
Equity (BVPS) 2.94
3.50
4.16
4.12
5.54
5.64
6.39
8.66
9.68
10.28
12.32
growth rate 19.1% 18.9% -1.0% 34.5% 1.8% 13.3% 35.5% 11.8% 6.2% 19.8%
Earnings BIT 72.08
83.63
100.46
116.14
131.04
growth rate 16.0% 20.1% 15.6% 12.8%
Avg.PE 49.94
45.08
36.67
growth rate -9.7% -18.7%
ROA 3.20
5.59
7.14
6.78
8.29
8.38
8.34
8.48
9.30
9.58
10.37
growth rate 74.7% 27.7% -5.0% 22.3% 1.1% -0.5% 1.7% 9.7% 3.0% 8.3%
ROE 5.37
8.75
10.06
9.21
12.28
12.94
12.44
12.31
13.81
14.50
16.02
growth rate 62.9% 15.0% -8.5% 33.3% 5.4% -3.9% -1.1% 12.2% 5.0% 10.5%
ROIC 3.96
7.49
8.96
8.78
10.64
10.35
10.36
10.53
11.67
12.10
12.94
growth rate 89.1% 19.6% -2.0% 21.2% -2.7% 0.1% 1.6% 10.8% 3.7% 6.9%
Cur. Ratio 2.17
2.27
2.31
2.56
2.43
2.55
2.46
2.67
2.31
2.41
2.51
growth rate 4.6% 1.8% 10.8% -5.1% 4.9% -3.5% 8.5% -13.5% 4.3% 4.2%
Quick Ratio 1.25
1.37
1.33
1.49
1.45
1.49
1.41
1.44
1.26
1.38
1.58
growth rate 9.6% -2.9% 12.0% -2.7% 2.8% -5.4% 2.1% -12.5% 9.5% 14.5%
Leverage 1.65
1.49
1.34
1.37
1.58
1.52
1.47
1.44
1.53
1.50
1.58
growth rate -9.7% -10.1% 2.2% 15.3% -3.8% -3.3% -2.0% 6.3% -2.0% 5.3%
Balance Sheet Jul '08 Jul '09 Jul '10 Jul '11 Jul '12 Jul '13 Jul '14 Jul '15 Jul '16 Jul '17 Jul '18
Acct.Receivable 62.23
69.81
93.33
110.66
118.64
growth rate 12.2% 33.7% 18.6% 7.2%
Acct.Payable 19.53
16.18
26.26
27.47
34.26
growth rate -17.1% 62.3% 4.6% 24.7%
Cur.Assets 163.91
188.36
222.74
257.37
338.24
growth rate 14.9% 18.3% 15.6% 31.4%
Total Assets 536.15
584.03
694.53
786.37
963.71
growth rate 8.9% 18.9% 13.2% 22.6%
Cash 31.78
31.72
28.37
36.58
94.10
growth rate -0.2% -10.6% 29.0% 157.2%
Inventory 59.74
72.08
91.49
98.72
107.59
growth rate 20.7% 26.9% 7.9% 9.0%
Cur.Liabilities 66.50
70.62
96.34
106.78
134.78
growth rate 6.2% 36.4% 10.8% 26.2%
Liabilities 170.90
177.40
240.16
262.44
354.84
growth rate 3.8% 35.4% 9.3% 35.2%
LT Debt 80.50
78.50
116.00
126.00
187.30
growth rate -2.5% 47.8% 8.6% 48.7%
Equity 365.25
406.63
454.37
523.93
608.87
growth rate 11.3% 11.7% 15.3% 16.2%
Common Shares 37.00
37.00
38.00
38.00
40.00
41.00
41.00
41.00
41.00
42.00
42.00
growth rate 0.0% 2.7% 0.0% 5.3% 2.5% 0.0% 0.0% 0.0% 2.4% 0.0%
Cash Flow Statement Jul '08 Jul '09 Jul '10 Jul '11 Jul '12 Jul '13 Jul '14 Jul '15 Jul '16 Jul '17 Jul '18
Capital Expenditures 13.54
12.76
18.89
27.07
37.70
growth rate -5.8% 48.0% 43.3% 39.3%
Cash Dividends 3.72
4.15
5.01
5.84
7.09
growth rate 11.6% 20.5% 16.7% 21.4%
Cash From OA 64.27
59.07
80.27
108.19
125.91
growth rate -8.1% 35.9% 34.8% 16.4%
FCF per Share 0.24
0.51
0.44
0.41
0.92
0.87
0.86
0.95
1.32
1.53
1.94
growth rate 112.5% -13.7% -6.8% 124.4% -5.4% -1.2% 10.5% 39.0% 15.9% 26.8%
Sale Purchase of Stock 0.63
0.61
-3.73
-6.91
growth rate -4.1% -100.0% 0.0%
FCF 14.00
27.00
23.00
22.00
45.00
45.00
51.00
46.00
61.00
81.00
88.00
growth rate 92.9% -14.8% -4.4% 104.6% 0.0% 13.3% -9.8% 32.6% 32.8% 8.6%
Income Statement Jul '08 Jul '09 Jul '10 Jul '11 Jul '12 Jul '13 Jul '14 Jul '15 Jul '16 Jul '17 Jul '18
Sales 488.75
560.64
662.72
770.16
871.92
growth rate 14.7% 18.2% 16.2% 13.2%
Op.Income 72.08
83.63
100.46
116.14
131.04
growth rate 16.0% 20.1% 15.6% 12.8%
IBT 68.61
76.19
93.93
106.23
117.51
growth rate 11.1% 23.3% 13.1% 10.6%
Net Income 43.27
47.95
59.95
71.38
91.04
growth rate 10.8% 25.0% 19.1% 27.6%
EPS 0.24
0.42
0.52
0.52
0.77
0.95
1.04
1.15
1.44
1.71
2.18
growth rate 75.0% 23.8% 0.0% 48.1% 23.4% 9.5% 10.6% 25.2% 18.8% 27.5%
Gross Profit 213.30
255.45
310.15
367.51
416.38
growth rate 19.8% 21.4% 18.5% 13.3%
R&D 10.81
14.02
15.41
18.37
24.65
growth rate 29.7% 9.9% 19.2% 34.2%

Quarterly Statements

Item Name Apr '18 Jul '18 Oct '18 Jan '19 Apr '19
Earnings BIT 32.11
30.13
30.30
29.25
27.72
growth rate -6.2% 0.6% -3.5% -5.2%
Balance Sheet Apr '18 Jul '18 Oct '18 Jan '19 Apr '19
Acct.Receivable 118.33
118.64
125.14
127.09
143.99
growth rate 0.3% 5.5% 1.6% 13.3%
Acct.Payable 36.63
34.26
41.98
35.14
50.54
growth rate -6.5% 22.6% -16.3% 43.8%
Cur.Assets 300.45
338.24
317.58
335.81
352.55
growth rate 12.6% -6.1% 5.7% 5.0%
Total Assets 921.97
963.71
983.60
1,022.03
1,062.79
growth rate 4.5% 2.1% 3.9% 4.0%
Cash 51.92
94.10
64.03
71.03
51.35
growth rate 81.3% -32.0% 10.9% -27.7%
Inventory 113.11
107.59
111.07
115.89
134.19
growth rate -4.9% 3.2% 4.3% 15.8%
Cur.Liabilities 123.33
134.78
143.79
122.65
151.07
growth rate 9.3% 6.7% -14.7% 23.2%
Liabilities 320.67
354.84
361.24
380.43
406.93
growth rate 10.7% 1.8% 5.3% 7.0%
LT Debt 169.00
187.30
184.94
227.58
223.21
growth rate 10.8% -1.3% 23.1% -1.9%
Equity 601.31
608.87
622.36
641.60
655.87
growth rate 1.3% 2.2% 3.1% 2.2%
Common Shares 4.05
4.62
4.63
4.63
4.64
growth rate 14.3% 0.2% 0.0% 0.1%
Cash Flow Statement Apr '18 Jul '18 Oct '18 Jan '19 Apr '19
Capital Expenditures 10.30
13.93
38.83
23.23
13.33
growth rate 35.3% 178.9% -40.2% -42.6%
Cash Dividends 0.00
3.55
4.17
4.17
growth rate 354,400.0% 17.7% 0.0%
Cash From OA 35.33
35.91
32.27
-3.08
19.29
growth rate 1.6% -10.1% -100.0% 100.0%
Sale Purchase of Stock -0.26
growth rate
FCF 25.04
21.98
-6.57
-26.30
5.97
growth rate -12.2% -100.0% 0.0% 100.0%
Income Statement Apr '18 Jul '18 Oct '18 Jan '19 Apr '19
Sales 217.27
228.85
225.59
224.54
228.55
growth rate 5.3% -1.4% -0.5% 1.8%
Op.Income 32.11
30.13
30.30
29.25
27.72
growth rate -6.2% 0.6% -3.5% -5.2%
IBT 25.57
29.01
25.65
25.30
12.30
growth rate 13.5% -11.6% -1.4% -51.4%
Net Income 18.74
16.89
19.24
18.80
8.18
growth rate -9.9% 13.9% -2.3% -56.5%
Gross Profit 104.69
107.76
105.47
104.71
107.54
growth rate 2.9% -2.1% -0.7% 2.7%
R&D 6.57
7.10
7.08
7.92
7.35
growth rate 8.1% -0.4% 11.9% -7.2%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (96.94)

YOY Growth Grade:

B (81.22)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 44.98 43.35
EPS / Growth 1.51

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 15.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 15.0% 15.0% 15.0%
Future PE 0.01 25.00 25.00
Future EPS 6.12 6.12 6.12
Value Price
MOS %
0.02
-100.0%
37.82
-42.3%
37.82
-42.3%
MOS Price 0.01 18.91 18.91
IRT 13.54 13.54 13.54

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.